Literature DB >> 23008484

Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells.

Brandon S J Davies1, Chris N Goulbourne, Richard H Barnes, Kirsten A Turlo, Peter Gin, Sue Vaughan, David J Vaux, André Bensadoun, Anne P Beigneux, Loren G Fong, Stephen G Young.   

Abstract

Lipoprotein lipase (LPL) is secreted into the interstitial spaces by adipocytes and myocytes but then must be transported to the capillary lumen by GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells. The mechanism by which GPIHBP1 and LPL move across endothelial cells remains unclear. We asked whether the transport of GPIHBP1 and LPL across endothelial cells was uni- or bidirectional. We also asked whether GPIHBP1 and LPL are transported across cells in vesicles and whether this transport process requires caveolin-1. The movement of GPIHBP1 and LPL across cultured endothelial cells was bidirectional. Also, GPIHBP1 moved bidirectionally across capillary endothelial cells in live mice. The transport of LPL across endothelial cells was inhibited by dynasore and genistein, consistent with a vesicular transport process. Also, transmission electron microscopy (EM) and dual-axis EM tomography revealed GPIHBP1 and LPL in invaginations of the plasma membrane and in vesicles. The movement of GPIHBP1 across capillary endothelial cells was efficient in the absence of caveolin-1, and there was no defect in the internalization of LPL by caveolin-1-deficient endothelial cells in culture. Our studies show that GPIHBP1 and LPL move bidirectionally across endothelial cells in vesicles and that transport is efficient even when caveolin-1 is absent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23008484      PMCID: PMC3494248          DOI: 10.1194/jlr.M031559

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  38 in total

1.  Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein.

Authors:  S M Vogel; R D Minshall; M Pilipović; C Tiruppathi; A B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-12       Impact factor: 5.464

2.  Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.

Authors:  M Drab; P Verkade; M Elger; M Kasper; M Lohn; B Lauterbach; J Menne; C Lindschau; F Mende; F C Luft; A Schedl; H Haller; T V Kurzchalia
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

3.  Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway.

Authors:  C Tiruppathi; W Song; M Bergenfeldt; P Sass; A B Malik
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

4.  Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1.

Authors:  Youchun Zeng; Nengbing Tao; Koong-Nah Chung; John E Heuser; Douglas M Lublin
Journal:  J Biol Chem       Date:  2003-08-28       Impact factor: 5.157

5.  Dual-axis tomography: an approach with alignment methods that preserve resolution.

Authors:  D N Mastronarde
Journal:  J Struct Biol       Date:  1997-12       Impact factor: 2.867

6.  Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase.

Authors:  Kenichi Yoshida; Tetsuya Shimizugawa; Mitsuru Ono; Hidehiko Furukawa
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

7.  Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.

Authors:  Babak Razani; Terry P Combs; Xiao Bo Wang; Philippe G Frank; David S Park; Robert G Russell; Maomi Li; Baiyu Tang; Linda A Jelicks; Philipp E Scherer; Michael P Lisanti
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

8.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

Authors:  B Razani; J A Engelman; X B Wang; W Schubert; X L Zhang; C B Marks; F Macaluso; R G Russell; M Li; R G Pestell; D Di Vizio; H Hou; B Kneitz; G Lagaud; G J Christ; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

9.  Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation.

Authors:  J C Yoon; T W Chickering; E D Rosen; B Dussault; Y Qin; A Soukas; J M Friedman; W E Holmes; B M Spiegelman
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

10.  Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport.

Authors:  J Peterson; B E Bihain; G Bengtsson-Olivecrona; R J Deckelbaum; Y A Carpentier; T Olivecrona
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

View more
  31 in total

Review 1.  Muscle microvasculature's structural and functional specializations facilitate muscle metabolism.

Authors:  Yvo H A M Kusters; Eugene J Barrett
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

2.  Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.

Authors:  Anne P Beigneux; Kazuya Miyashita; Michael Ploug; Dirk J Blom; Masumi Ai; MacRae F Linton; Weerapan Khovidhunkit; Robert Dufour; Abhimanyu Garg; Maureen A McMahon; Clive R Pullinger; Norma P Sandoval; Xuchen Hu; Christopher M Allan; Mikael Larsson; Tetsuo Machida; Masami Murakami; Karen Reue; Peter Tontonoz; Ira J Goldberg; Philippe Moulin; Sybil Charrière; Loren G Fong; Katsuyuki Nakajima; Stephen G Young
Journal:  N Engl J Med       Date:  2017-04-05       Impact factor: 91.245

3.  Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL.

Authors:  Xuchen Hu; Mark W Sleeman; Kazuya Miyashita; MacRae F Linton; Christopher M Allan; Cuiwen He; Mikael Larsson; Yiping Tu; Norma P Sandoval; Rachel S Jung; Alaleh Mapar; Tetsuo Machida; Masami Murakami; Katsuyuki Nakajima; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2016-11-15       Impact factor: 5.922

Review 4.  Emerging Roles of Vascular Endothelium in Metabolic Homeostasis.

Authors:  Xinchun Pi; Liang Xie; Cam Patterson
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

5.  High-resolution imaging of dietary lipids in cells and tissues by NanoSIMS analysis.

Authors:  Haibo Jiang; Chris N Goulbourne; Angelica Tatar; Kirsten Turlo; Daniel Wu; Anne P Beigneux; Chris R M Grovenor; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

6.  A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time.

Authors:  Shwetha K Shetty; Rosemary L Walzem; Brandon S J Davies
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

7.  Syndecan-1 Mediates Sorting of Soluble Lipoprotein Lipase with Sphingomyelin-Rich Membrane in the Golgi Apparatus.

Authors:  Emma L Sundberg; Yongqiang Deng; Christopher G Burd
Journal:  Dev Cell       Date:  2019-09-19       Impact factor: 12.270

Review 8.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

9.  Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation.

Authors:  Michael J Lafferty; Kira C Bradford; Dorothy A Erie; Saskia B Neher
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

Review 10.  GPIHBP1 and Plasma Triglyceride Metabolism.

Authors:  Loren G Fong; Stephen G Young; Anne P Beigneux; André Bensadoun; Monika Oberer; Haibo Jiang; Michael Ploug
Journal:  Trends Endocrinol Metab       Date:  2016-05-14       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.